Wouter ter Veer

619 total citations
13 papers, 529 citations indexed

About

Wouter ter Veer is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Wouter ter Veer has authored 13 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 9 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Wouter ter Veer's work include Influenza Virus Research Studies (12 papers), Immune Response and Inflammation (6 papers) and Immune Cell Function and Interaction (4 papers). Wouter ter Veer is often cited by papers focused on Influenza Virus Research Studies (12 papers), Immune Response and Inflammation (6 papers) and Immune Cell Function and Interaction (4 papers). Wouter ter Veer collaborates with scholars based in Netherlands, Belgium and Hungary. Wouter ter Veer's co-authors include Anke Huckriede, Jan Wilschut, Laura Bungener, Felix Geeraedts, Jan Paul Medema, Wouter L.J. Hinrichs, Henderik W. Frijlink, Judith G. Pool, Toos Daemen and Vinay Saluja and has published in prestigious journals such as Journal of Virology, Journal of Controlled Release and Vaccine.

In The Last Decade

Wouter ter Veer

13 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wouter ter Veer Netherlands	12	303	254	140	111	53	13	529
Jun‐ichi Maeyama Japan	17	210 0.7×	372 1.5×	220 1.6×	149 1.3×	14 0.3×	33	722
G.J.M. van Scharrenburg Netherlands	7	240 0.8×	193 0.8×	95 0.7×	198 1.8×	18 0.3×	10	482
Pascale Van Belle Belgium	7	274 0.9×	190 0.7×	108 0.8×	109 1.0×	17 0.3×	7	463
Linda Stertman Sweden	12	105 0.3×	246 1.0×	159 1.1×	248 2.2×	13 0.2×	17	563
Luis Garcı́a Cuba	14	161 0.5×	169 0.7×	174 1.2×	95 0.9×	20 0.4×	35	653
Daniele Casini Italy	7	181 0.6×	262 1.0×	176 1.3×	149 1.3×	8 0.2×	8	475
J. M. Rodrigues Brazil	10	148 0.5×	131 0.5×	129 0.9×	153 1.4×	10 0.2×	10	444
Habtom H. Habte United States	10	75 0.2×	87 0.3×	143 1.0×	93 0.8×	17 0.3×	12	367
Yo Han Jang South Korea	16	367 1.2×	188 0.7×	228 1.6×	182 1.6×	16 0.3×	42	678
Arnaud Machelart France	14	153 0.5×	151 0.6×	127 0.9×	115 1.0×	36 0.7×	25	488

Countries citing papers authored by Wouter ter Veer

Since Specialization

Citations

This map shows the geographic impact of Wouter ter Veer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter ter Veer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter ter Veer more than expected).

Fields of papers citing papers by Wouter ter Veer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wouter ter Veer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter ter Veer. The network helps show where Wouter ter Veer may publish in the future.

Co-authorship network of co-authors of Wouter ter Veer

This figure shows the co-authorship network connecting the top 25 collaborators of Wouter ter Veer. A scholar is included among the top collaborators of Wouter ter Veer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter ter Veer. Wouter ter Veer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Patil, Harshad P., Wouter ter Veer, Tjarko Meijerhof, et al.. (2013). Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine. Journal of Controlled Release. 174. 51–62. 48 indexed citations

Patil, Harshad P., Wouter ter Veer, Tjarko Meijerhof, et al.. (2013). Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: Comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants. European Journal of Pharmaceutics and Biopharmaceutics. 85(3). 716–725. 33 indexed citations

Liu, Heng, Jacqueline de Vries‐Idema, Wouter ter Veer, Jan Wilschut, & Anke Huckriede. (2013). Influenza virosomes supplemented with GPI-0100 adjuvant: a potent vaccine formulation for antigen dose sparing. Medical Microbiology and Immunology. 203(1). 47–55. 12 indexed citations

Vanderlinden, Evelien, Els Vanstreels, Wouter ter Veer, et al.. (2012). Intracytoplasmic Trapping of Influenza Virus by a Lipophilic Derivative of Aglycoristocetin. Journal of Virology. 86(17). 9416–9431. 33 indexed citations

Geeraedts, Felix, Wouter ter Veer, Jan Wilschut, Anke Huckriede, & Aalzen de Haan. (2012). Effect of viral membrane fusion activity on antibody induction by influenza H5N1 whole inactivated virus vaccine. Vaccine. 30(45). 6501–6507. 7 indexed citations

Liu, Heng, Laura Bungener, Wouter ter Veer, et al.. (2011). Preclinical evaluation of the saponin derivative GPI-0100 as an immunostimulating and dose-sparing adjuvant for pandemic influenza vaccines. Vaccine. 29(11). 2037–2043. 21 indexed citations

Saluja, Vinay, M.R. Visser, Wouter ter Veer, et al.. (2010). Influenza antigen-sparing by immune stimulation with Gram-positive enhancer matrix (GEM) particles. Vaccine. 28(50). 7963–7969. 29 indexed citations

Geeraedts, Felix, Vinay Saluja, Wouter ter Veer, et al.. (2010). Preservation of the Immunogenicity of Dry-powder Influenza H5N1 Whole Inactivated Virus Vaccine at Elevated Storage Temperatures. The AAPS Journal. 12(2). 215–222. 51 indexed citations

Geeraedts, Felix, Laura Bungener, Judith G. Pool, et al.. (2008). Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs. Influenza and Other Respiratory Viruses. 2(2). 41–51. 74 indexed citations

10.

Bungener, Laura, Felix Geeraedts, Wouter ter Veer, et al.. (2008). Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection. Vaccine. 26(19). 2350–2359. 131 indexed citations

11.

Vries, Jutte J.C. de, Laura Bungener, Wouter ter Veer, et al.. (2008). Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity. Vaccine. 27(6). 947–955. 24 indexed citations

12.

Huckriede, Anke, Laura Bungener, Wouter ter Veer, et al.. (2003). Influenza virosomes: combining optimal presentation of hemagglutinin with immunopotentiating activity. Vaccine. 21(9-10). 925–931. 43 indexed citations

13.

Bungener, Laura, et al.. (2002). VIROSOMES IN VACCINE DEVELOPMENT: INDUCTION OF CYTOTOXIC T LYMPHOCYTE ACTIVITY WITH VIROSOME-ENCAPSULATED PROTEIN ANTIGENS. Journal of Liposome Research. 12(1-2). 155–163. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact